Medical News

RSS

New study shows 'alarming rise' in costs of MS drugs over last 20 years

A new study shows an "alarming rise" over the last 20 years in the costs of drugs used to slow the progression of multiple sclerosis or reduce the frequency of attacks, according to a study led by researchers at Oregon Health & Science University and Oregon State University.

25 Apr 2015

New study reveals that psychiatric disorders don't predict future violent behavior

Most psychiatric disorders - including depression -- do not predict future violent behavior, according to new Northwestern Medicine longitudinal study of delinquent youth. The only exception is substance abuse and dependence.

25 Apr 2015

Understanding how nerve cells in the brain produce energy required to function

New research published today in the journal Nature Communications represents a potentially fundamental shift in our understanding of how nerve cells in the brain generate the energy needed to function. The study shows neurons are more independent than previously believed and this research has implications for a range of neurological disorders.

25 Apr 2015

Orphaned children face high risk of trauma

Orphaned children in low- and middle-income countries face a high risk of trauma, with physical and sexual abuse being by far the most prevalent traumatic events.

25 Apr 2015

New method could help scientists spot source of disease-causing mutations in enhancers

A new technique that identifies how genes are controlled could help scientists spot errors in the genetic code which trigger disease, a study suggests.

25 Apr 2015

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Coeliac disease is one of the most common life-long conditions in Europe, yet many people remain undiagnosed and lengthy diagnostic delays may be putting lives at risk. Today, doctors are being urged to consider testing for Coeliac disease in anyone showing signs and symptoms of the condition and to consider screening everyone in high-risk groups.

25 Apr 2015

Loyola's study on simulated stroke earns prestigious 2015 Safety and Quality Award

A study performed by Loyola University Medical Center resident neurologists has won a prestigious 2015 Safety and Quality Award from the American Academy of Neurology.

25 Apr 2015

Loyola study reports significant increase in major depression during recent Great Recession

The recent Great Recession was accompanied by a significant and sustained increase in major depression in U.S. adults, according to a Loyola study published in the Journal of Clinical Psychiatry.

25 Apr 2015

Toyohashi Tech researchers develop novel cell-manipulation tool to trap, release single cells in microwells

Functional analysis of a cell, which is the fundamental unit of life, is important for gaining new insights into medical and pharmaceutical fields. For efficiently studying cell functions, it is essential to reconstruct cellular microenvironments by parallel manipulation of single cells. Various cell manipulation techniques including fluidic, optical, and electrical techniques have been developed.

25 Apr 2015

Study identifies BLU-554 as potential treatment option for HCC patients

Findings were presented today at The International Liver CongressTM 2015 on a novel therapeutic candidate for a genomically defined subset of hepatocellular carcinoma (HCC) patients with an aberrant fibroblast growth factor receptor 4 (FGFR4) pathway.

25 Apr 2015

Study shows NASH linked to 50% higher death rates compared with NAFLD

Results from a large population-based cohort of almost a million people in the UK found that the chances of dying from non-alcoholic steatohepatitis (NASH), over a 14-year period, was approximately 50% higher than for those with non-alcoholic fatty liver disease (NAFLD).

25 Apr 2015

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Results announced today at The International Liver Congress 2015 show that cancer rates in patients with the hepatitis C virus (HCV) were significantly increased compared to the non-HCV cohort. The researchers suggest an extrahepatic manifestation of HCV may be an increased risk of cancer.

25 Apr 2015

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis plc today announced positive top-line results for study DUR001-303, a phase 3 study comparing a single 1500 mg dose of DALVANCE with the same total dose given as two-doses one week apart, for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA).

25 Apr 2015

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older.

25 Apr 2015

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology.

From Natera 25 Apr 2015

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine.

25 Apr 2015

Xstrahl introduces Phtotoelectric therapy to the European market at ESTRO 2015

Utilising trusted and clinically proven low energy photons, in a dedicated treatment system. Photoelectric Therapy provides a pain free, non-surgical alternative for the treatment of non-melanoma skin cancer, especially those found in sensitive areas of the head and neck...

24 Apr 2015

Porvair Previews New Microplate Products at ACHEMA

Visitors to ACHEMA 2015 have been invited by Porvair Sciences to Stand F44 in Halle 4.2 to see their expansive range of application optimised microplates and microplate equipment...

From Porvair Sciences Limited 24 Apr 2015

Asthma breakthrough: potential cause and corrective treatment are identified

A paper published yesterday in Science Translational Medicine reports that the root cause of asthma has been found and a potential treatment to reverse all symptoms has been proposed...

24 Apr 2015

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Baby-Friendly USA announced this week that Children's Memorial Hermann Hospital has received prestigious international recognition as a Baby-Friendly designated birth facility. A hospital can only be deemed "Baby-Friendly" after the completion of a rigorous onsite assessment survey and a final review of the External Review Board.

24 Apr 2015

Medical News

New study shows 'alarming rise' in costs of MS drugs over last 20 years

New study reveals that psychiatric disorders don't predict future violent behavior

Understanding how nerve cells in the brain produce energy required to function

Orphaned children face high risk of trauma

New method could help scientists spot source of disease-causing mutations in enhancers

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Loyola's study on simulated stroke earns prestigious 2015 Safety and Quality Award

Loyola study reports significant increase in major depression during recent Great Recession

Toyohashi Tech researchers develop novel cell-manipulation tool to trap, release single cells in microwells

Study identifies BLU-554 as potential treatment option for HCC patients

Study shows NASH linked to 50% higher death rates compared with NAFLD

Study: Cancer rates in HCV patients significantly increase compared to non-HCV cohort

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Xstrahl introduces Phtotoelectric therapy to the European market at ESTRO 2015

Porvair Previews New Microplate Products at ACHEMA

Asthma breakthrough: potential cause and corrective treatment are identified

Children's Memorial Hermann Hospital attains Baby-Friendly designation

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News